|
Performance Benchmark: Optimizing Marketing Staff Levels to Drive GrowthPublished by: Best Practices, LLC Published: Dec. 1, 2008 - 60 Pages Table of Contents
AbstractThis benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.The benchmarks developed by this assessment are prepared to aid marketing organizations with direction for strategic and tactical marketing activities to support their product portfolios in optimizing growth and profitability rates. The study engaged more than 60 marketing leaders in field research, probing critical marketing productivity factors. Among the questions that this research addressed are the following:
Health Care; Pharmaceutical; Biotechnology; Chemical; Technology; Manufacturing COMPANIES PROFILED Abbott; Pharmacopeia; American Regent; Cardinal Health; BARD; PDL; BD; LifeScan; Intas; Jazz Pharmaceuticals; Hospira; Medrad; Luitpold; Pfizer; MSD; Medtronic; Nupathe; Baxter Healthcare; Response; Stryker; Teun; Roche; YM Biosciences; Respironics; Johnson & Johnson; Sanofi-Aventis; Amylin; Smiths Medical; Merck Serono; Solvay Pharmaceuticals; Covidien; Talecris; Novartis; Theravance; Alcon; Watson Pharmaceuticals; Emcure; Aton Pharma; Genzyme; Amgen STUDY SNAPSHOT Sixty marketing executives representing either full-company or unique business unit perspectives participated in the field research representing forty-five bio-pharmaceutical, medical device and generic companies. KEY FINDINGS Marketing improvement opportunities reside along four fronts & opportunity type varies across different business units:
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||